PIONEER
Research Project |
|
A 3-part, randomized, double-blind, placebo-controlled phase 2 study to evaluate safety and efficacy of Avapritinib (BLU-285) in indolent and smoldering systemic mastocytosis
Members (1)
UNIverse - Public Research Portal
Research Project